It depends on which best suits your lifestyle and what kind of results you would like to see
Who Should Proceed With Caution Men with a history of hormone-sensitive cancers Those with uncontrolled diabetes or significant metabolic disease Men with active cardiovascular conditions Anyone with pituitary disorders Those taking medications that may interact with hormone therapies What to Expect: Timeline of Results Results from a peptide and TRT stack develop progressively: Individual timelines vary based on starting hormone levels, age, training status, and adherence to the protocol
It is mainly used to control blood sugar, but researchers suspect the drug may also reduce inflammation in the kidneys and throughout the body
Preclinical research has demonstrated these mechanisms extensively, though human clinical trials specific to IGF-1 LR3 are still limited
In addition, surface transporters of epithelial cells, such as glucose transporter GLUT2 and amino acid transporter SGLT1, can specifically transport nutrients, further enhancing the selectivity of permeability
doi: 10.1038/s41430-019-0434-9 47 ShamasbiSGGhanbari-HomayiSMirghafourvandM